Endocrinology, Vol 137, 4752-4756, Copyright © 1996 by Endocrine Society

ARTICLES

Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions

SD Stroop, H Nakamuta, RE Kuestner, EE Moore and RM Epand
ZymoGenetics, Inc., Seattle, Washington 98102, USA. stroops@zgi.com

High affinity binding was characterized for a number of salmon calcitonin (sCT) analogs to a chimeric receptor (NtCTr) constructed by splicing the N-terminal domain of the human CT receptor onto the C- terminal, transmembrane loop region of the receptor for glucagon. Another chimeric receptor (NtGGr) with the N-terminal domain of the glucagon receptor spliced onto the C-terminal regions of the CT receptor shows no high affinity binding of sCT. Nevertheless, sCT and a number of analogs of the hormone are able to elevate cAMP levels in cells transfected with NtGGr. The least helical analog, des-1-amino- [Ala1,7,Gly8]des-Leu19-sCT, is one of the most active in this regard. Two hormone analogs with modifications in the amino-terminal region, des-Ser2-sCT and [Gly2,3,4,5,6]sCT, show reduced or no activity, respectively, for elevating cAMP in cells expressing the NtGGr. In addition, a 15-fold excess of the peptide sCT-(8-32) antagonizes sCT activation of this receptor. In contrast, these calcitonin analogs exhibited a different rank order for binding to the NtCTr receptor. In fact, des-Ser2-sCT and [Gly8]-des-Leu19-sCT along with the native hormone had the highest helical content as well as the highest binding affinities to the NtCTr receptor. These studies suggest that the helical portion of the hormone within residues 8-22 of sCT is the principal determinant for binding to the receptor N-terminus. Residues 2-6 of sCT interact with the receptor transmembrane loop region and are critical for activation of adenylate cyclase; however, residues 8-32, including Leu16, are responsible for most of the hormone interaction with the transmembrane loop region. Thus, unique requirements exist for CT interaction at the receptor N-terminus relative to the receptor transmembrane loop region, yet there is significant overlap in the hormone determinants that facilitate these interactions.

This article has been cited by other articles:

				M. Dong, F. Gao, D. I. Pinon, and L. J. Miller Insights into the Structural Basis of Endogenous Agonist Activation of Family B G Protein-Coupled Receptors Mol. Endocrinol., June 1, 2008; 22(6): 1489 - 1499. [Abstract] [Full Text] [PDF]

				G. Andreotti, B. L. Mendez, P. Amodeo, M. A. C. Morelli, H. Nakamuta, and A. Motta Structural Determinants of Salmon Calcitonin Bioactivity: THE ROLE OF THE LEU-BASED AMPHIPATHIC {alpha}-HELIX J. Biol. Chem., August 25, 2006; 281(34): 24193 - 24203. [Abstract] [Full Text] [PDF]

				M. DONG and L. J. MILLER Use of Photoaffinity Labeling to Understand the Molecular Basis of Ligand Binding to the Secretin Receptor Ann. N.Y. Acad. Sci., July 1, 2006; 1070(1): 248 - 264. [Abstract] [Full Text] [PDF]

				V. Pham, M. Dong, J. D. Wade, L. J. Miller, C. J. Morton, H.-l. Ng, M. W. Parker, and P. M. Sexton Insights into Interactions between the {alpha}-Helical Region of the Salmon Calcitonin Antagonists and the Human Calcitonin Receptor using Photoaffinity Labeling J. Biol. Chem., August 5, 2005; 280(31): 28610 - 28622. [Abstract] [Full Text] [PDF]

				M. Dong, D. I. Pinon, R. F. Cox, and L. J. Miller Molecular Approximation between a Residue in the Amino-terminal Region of Calcitonin and the Third Extracellular Loop of the Class B G Protein-coupled Calcitonin Receptor J. Biol. Chem., July 23, 2004; 279(30): 31177 - 31182. [Abstract] [Full Text] [PDF]

				K. Wagner, N. Van Mau, S. Boichot, A. V. Kajava, U. Krauss, C. Le Grimellec, A. Beck-Sickinger, and F. Heitz Interactions of the Human Calcitonin Fragment 9-32 with Phospholipids: A Monolayer Study Biophys. J., July 1, 2004; 87(1): 386 - 395. [Abstract] [Full Text] [PDF]

				V. Pham, J. D. Wade, B. W. Purdue, and P. M. Sexton Spatial Proximity between a Photolabile Residue in Position 19 of Salmon Calcitonin and the Amino Terminus of the Human Calcitonin Receptor J. Biol. Chem., February 20, 2004; 279(8): 6720 - 6729. [Abstract] [Full Text] [PDF]

				M. Dong, D. I. Pinon, R. F. Cox, and L. J. Miller Importance of the Amino Terminus in Secretin Family G Protein-coupled Receptors: INTRINSIC PHOTOAFFINITY LABELING ESTABLISHES INITIAL DOCKING CONSTRAINTS FOR THE CALCITONIN RECEPTOR J. Biol. Chem., January 9, 2004; 279(2): 1167 - 1175. [Abstract] [Full Text] [PDF]

				R. Lopez de Maturana, A. Willshaw, A. Kuntzsch, R. Rudolph, and D. Donnelly The Isolated N-terminal Domain of the Glucagon-like Peptide-1 (GLP-1) Receptor Binds Exendin Peptides with Much Higher Affinity than GLP-1 J. Biol. Chem., March 14, 2003; 278(12): 10195 - 10200. [Abstract] [Full Text] [PDF]

				J.-P. Vilardaga, I. Lin, and R. A. Nissenson Analysis of Parathyroid Hormone (PTH)/Secretin Receptor Chimeras Differentiates the Role of Functional Domains in the PTH/ PTH-Related Peptide (PTHrP) Receptor on Hormone Binding and Receptor Activation Mol. Endocrinol., July 1, 2001; 15(7): 1186 - 1199. [Abstract] [Full Text] [PDF]

				Y. W. Asmann, M. Dong, S. Ganguli, E. M. Hadac, and L. J. Miller Structural Insights into the Amino-Terminus of the Secretin Receptor: I. Status of Cysteine and Cystine Residues Mol. Pharmacol., November 1, 2000; 58(5): 911 - 919. [Abstract] [Full Text]

				U. Gether Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors Endocr. Rev., February 1, 2000; 21(1): 90 - 113. [Abstract] [Full Text]

				H. H. Ho, D. Du, and M. C. Gershengorn The N Terminus of Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Is Necessary for High Affinity Chemokine Binding but Not for Constitutive Activity J. Biol. Chem., October 29, 1999; 274(44): 31327 - 31332. [Abstract] [Full Text] [PDF]

				S. L. Ferrari, V. Behar, M. Chorev, M. Rosenblatt, and A. Bisello Endocytosis of Ligand-Human Parathyroid Hormone Receptor 1 Complexes Is Protein Kinase C-dependent and Involves beta -Arrestin2. REAL-TIME MONITORING BY FLUORESCENCE MICROSCOPY J. Biol. Chem., October 15, 1999; 274(42): 29968 - 29975. [Abstract] [Full Text] [PDF]

				M. Dong, Y. Wang, E. M. Hadac, D. I. Pinon, E. Holicky, and L. J. Miller Identification of an Interaction between Residue 6 of the Natural Peptide Ligand and a Distinct Residue within the Amino-terminal Tail of the Secretin Receptor J. Biol. Chem., July 2, 1999; 274(27): 19161 - 19167. [Abstract] [Full Text] [PDF]

				M. Dong, Y. Wang, D. I. Pinon, E. M. Hadac, and L. J. Miller Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling J. Biol. Chem., January 8, 1999; 274(2): 903 - 909. [Abstract] [Full Text] [PDF]

				T. H. Ji, M. Grossmann, and I. Ji G Protein-coupled Receptors. I. DIVERSITY OF RECEPTOR-LIGAND INTERACTIONS J. Biol. Chem., July 10, 1998; 273(28): 17299 - 17302. [Full Text] [PDF]

				P. R. Turner, S. Mefford, T. Bambino, and R. A. Nissenson Transmembrane Residues Together with the Amino Terminus Limit the Response of the Parathyroid Hormone (PTH) 2 Receptor to PTH-related Peptide J. Biol. Chem., February 13, 1998; 273(7): 3830 - 3837. [Abstract] [Full Text] [PDF]

				M. H. Perrin, S. Sutton, D. L. Bain, W. T. Berggren, and W. W. Vale The First Extracellular Domain of Corticotropin Releasing Factor-R1 Contains Major Binding Determinants for Urocortin and Astressin Endocrinology, February 1, 1998; 139(2): 566 - 570. [Abstract] [Full Text] [PDF]

				L. J. Deftos, MD Editorial: There's Something Fishy and Perhaps Even Fowl about the Mammalian Calcitonin Receptor and Its Ligand Endocrinology, February 1, 1997; 138(2): 519 - 520. [Full Text] [PDF]

				S. R. J. Hoare, J. A. Clark, and T. B. Usdin Molecular Determinants of Tuberoinfundibular Peptide of 39 Residues (TIP39) Selectivity for the Parathyroid Hormone-2 (PTH2) Receptor. N-TERMINAL TRUNCATION OF TIP39 REVERSES PTH2 RECEPTOR/PTH1 RECEPTOR BINDING SELECTIVITY J. Biol. Chem., August 25, 2000; 275(35): 27274 - 27283. [Abstract] [Full Text] [PDF]